These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6036889)

  • 1. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.
    Zygmunt WA; Browder HP; Tavormina PA
    Appl Microbiol; 1968 Aug; 16(8):1168-73. PubMed ID: 5675508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
    Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
    J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus response to lysostaphin in some fermented foods.
    Metcalf RH; Deibel RH
    Appl Microbiol; 1969 Jan; 17(1):63-7. PubMed ID: 5774763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies with lysostaphin. I. Lysostaphin sensitivity of 355 strains of Staph. aureus of human origin].
    Pulverer G
    Z Med Mikrobiol Immunol; 1968; 154(1):40-8. PubMed ID: 5710870
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of lysostaphin and its two active components on stable wall-defective forms of Staphylococcus aureus.
    Watanakunakorn C; Browder HP
    J Infect Dis; 1970 Feb; 121(2):124-8. PubMed ID: 5197995
    [No Abstract]   [Full Text] [Related]  

  • 9. Lysostaphin.
    Koening MG
    J Infect Dis; 1969 Jan; 119(1):101-2. PubMed ID: 5191239
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A; Mond J; Walsh S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of lysostaphin-treated cells of Staphylococcus aureus.
    Riggs HG; Rosenblum ED
    J Virol; 1969 Jan; 3(1):33-7. PubMed ID: 4239098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Lif, the lysostaphin immunity factor, on acceptors of surface proteins and cell wall sorting efficiency in Staphylococcus carnosus.
    Strauss A; Thumm G; Götz F
    J Bacteriol; 1998 Sep; 180(18):4960-2. PubMed ID: 9733703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin-resistant coagulase-negative staphylococcus.
    Wilson AP; O'Hare MD; Felmingham D; Grüneberg RN
    Lancet; 1986 Oct; 2(8513):973. PubMed ID: 2877149
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Determination of Resistance to Antibiotic Inhibitors of Protein Synthesis in Staphylococcus aureus Through In Situ Evaluation of DNase Activity.
    Otero F; Santiso R; López I; Touzón I; Gosálvez J; Bou G; Fernández JL
    Microb Drug Resist; 2018; 24(6):739-746. PubMed ID: 29608387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cell walls of Staphylococcus aureus resistant to methicillin.
    Sabath LD; Leaf CD; Gerstein DA; Finland M
    Nature; 1970 Mar; 225(5237):1074. PubMed ID: 5198089
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of coagulase-negative staphylococci to transfer antibiotic resistance to Staphylococcus aureus 1030 in mixed cultures.
    Fawcett CJ; Lord VL; Lacey RW
    J Gen Microbiol; 1981 Oct; 126(2):507-9. PubMed ID: 7338731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
    Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
    Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to lysostaphin as a criterion for the identification of staphylococci from animal origin.
    Gutiérrez L; Menes I; Garcia ML; Moreno B
    J Appl Bacteriol; 1981 Jun; 50(3):541-9. PubMed ID: 7251519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.